Artwork

Unusual Whales द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Unusual Whales या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal
Player FM - पॉडकास्ट ऐप
Player FM ऐप के साथ ऑफ़लाइन जाएं!

Unusual Whales Pod Ep. 43: GLP-1 Therapies for Obesity and Overall Health, Sponsored by Tema $HRTS ETF

1:22:17
 
साझा करें
 

Manage episode 441659162 series 3384473
Unusual Whales द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Unusual Whales या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal

Unusual Whales Pod Ep. 43: GLP-1 Therapies for Obesity and Overall Health, Sponsored by Tema $HRTS ETF

This episode of the Unusual Whales Pod was recorded Live on September 24th, 2024. Our host is joined by the CEO and CIO of Tema ETFs Maurits Pot and Yuri Khodjamirian, as well as medical and Biopharma experts to discuss the health landscape in regards to Obesity. A range of topics from GLP-1 treatment efficacy such as Ozempic and Wegovy, to the investor’s point of view and how to navigate the potentially volatile world of biopharma stocks. Via their actively managed GLP-1, Obesity & Cardiometabolic ETF, ticker $HRTS, Tema stays on top of developments in the field, and invests in what they say may be the biggest biopharma potential in the markets, right now.

Panel:

Maurits Pot https://x.com/mauritspot

Yuri Khodjamirian https://x.com/YuriKhodjam

Eric Feigl-Ding https://x.com/DrEricDing

Alexandra Sowa https://x.com/AlexandraSowaMD

BioPharmCatalyst https://twitter.com/BPharmCatalyst

Hosted by:

Nicholas FNS: https://twitter.com/NicholasFNS

Unusual Whales: https://twitter.com/unusual_whales

**

Disclaimer:

Any content referenced in the video or on Unusual Whales are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. You can lose some or all of your investment. See terms for more information.

  continue reading

44 एपिसोडस

Artwork
iconसाझा करें
 
Manage episode 441659162 series 3384473
Unusual Whales द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री Unusual Whales या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal

Unusual Whales Pod Ep. 43: GLP-1 Therapies for Obesity and Overall Health, Sponsored by Tema $HRTS ETF

This episode of the Unusual Whales Pod was recorded Live on September 24th, 2024. Our host is joined by the CEO and CIO of Tema ETFs Maurits Pot and Yuri Khodjamirian, as well as medical and Biopharma experts to discuss the health landscape in regards to Obesity. A range of topics from GLP-1 treatment efficacy such as Ozempic and Wegovy, to the investor’s point of view and how to navigate the potentially volatile world of biopharma stocks. Via their actively managed GLP-1, Obesity & Cardiometabolic ETF, ticker $HRTS, Tema stays on top of developments in the field, and invests in what they say may be the biggest biopharma potential in the markets, right now.

Panel:

Maurits Pot https://x.com/mauritspot

Yuri Khodjamirian https://x.com/YuriKhodjam

Eric Feigl-Ding https://x.com/DrEricDing

Alexandra Sowa https://x.com/AlexandraSowaMD

BioPharmCatalyst https://twitter.com/BPharmCatalyst

Hosted by:

Nicholas FNS: https://twitter.com/NicholasFNS

Unusual Whales: https://twitter.com/unusual_whales

**

Disclaimer:

Any content referenced in the video or on Unusual Whales are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. You can lose some or all of your investment. See terms for more information.

  continue reading

44 एपिसोडस

सभी एपिसोड

×
 
Loading …

प्लेयर एफएम में आपका स्वागत है!

प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।

 

त्वरित संदर्भ मार्गदर्शिका